High target disease prevalence, technological advancements and favorable research funding scenario are key factors contributing to high CAGR of Apheresis Equipment during forecast period.
Market Size – USD 1.62 Billion in 2018, Market Growth - CAGR of 7.8%, Market Trends – Technological advancements and research and development for launch of advanced Apheresis Equipment
According to the current analysis of Reports and Data, the global Apheresis Equipment market was valued at USD 1.62 Billion in 2018 and is expected to reach USD 2.98 Billion by year 2026, at a CAGR of 7.8%. Apheresis is a medical procedure that involves removing the whole blood from a donor or a patient and separating the blood into individual components so that a particular component can be removed. It is a non-invasive procedure and takes less than a few hours. Thus, the procedure is favored by the people. The procedure is also known as Pheresis or Hemapheresis. The procedure is performed outside the body and is therefore an extracorporeal procedure.
In the recent times there has been an increase in the number of people suffering from leukemia, cancer. This has resulted in a need for plasma transfusions. This has further led to a rise in the demand for apheresis equipment. The biggest restraining factor of this market are the risks of this procedure. Risks such as, bleeding, infection, low blood pressure, muscle cramps etc. demotivate the people from opting this procedure.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1680
The report initially offers market introduction, market overview, product scope, market opportunities, growth prospects, risks, limitations, and key drivers. The report also covers a comprehensive analysis of the competitive landscape with extensive profiling of the key competitors. It covers recent technological advancements, product developments, product launches, mergers and acquisitions, collaborations, joint ventures, and partnerships.
Top companies profiled in the report include:
Terumo BCT Inc., B. Braun Melsungen AG, Fresenius Medical Care, Asahi Kasei Medical Co. Ltd., Haemonetics Corporation and HemaCare Corporation.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1680
The report also covers SWOT analysis and Porter’s Five Forces analysis along with feasibility analysis and investment return analysis. Key statistical data has been organized in tables, charts, diagrams, figures, and other pictorial representations. The report also offers strategic recommendations to established players as well as details on entry barriers for new entrants.
Further key findings from the report suggest
• Rising number of target diseases and blood disorders has led to a need for plasma and platelets across the globe. This has led a rise in the demand for apheresis which consequently has led to an increase in the demand for apheresis equipment.
• With the growing infrastructure there has been a rise in the number of established blood banks with proper equipment and facilities. The expansion of these blood banks has resulted in a rise in the demand for apheresis equipment.
• The governments of several countries are trying to build better infrastructure for the healthcare sector. This has led to a significant increase in the demand for the equipment.
• The continuous research and development for the launch of improved and more efficient equipment has, also, encouraged market demand.


High target disease prevalence, technological advancements and favorable research funding scenario are key factors contributing to high CAGR of Apheresis Equipment during forecast period. Market Size – USD 1.62 Billion in 2018, Market Growth - CAGR of 7.8%, Market Trends – Technological advancements and research and development for launch of advanced Apheresis Equipment According to the current analysis of Reports and Data, the global Apheresis Equipment market was valued at USD 1.62 Billion in 2018 and is expected to reach USD 2.98 Billion by year 2026, at a CAGR of 7.8%. Apheresis is a medical procedure that involves removing the whole blood from a donor or a patient and separating the blood into individual components so that a particular component can be removed. It is a non-invasive procedure and takes less than a few hours. Thus, the procedure is favored by the people. The procedure is also known as Pheresis or Hemapheresis. The procedure is performed outside the body and is therefore an extracorporeal procedure. In the recent times there has been an increase in the number of people suffering from leukemia, cancer. This has resulted in a need for plasma transfusions. This has further led to a rise in the demand for apheresis equipment. The biggest restraining factor of this market are the risks of this procedure. Risks such as, bleeding, infection, low blood pressure, muscle cramps etc. demotivate the people from opting this procedure. Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1680 The report initially offers market introduction, market overview, product scope, market opportunities, growth prospects, risks, limitations, and key drivers. The report also covers a comprehensive analysis of the competitive landscape with extensive profiling of the key competitors. It covers recent technological advancements, product developments, product launches, mergers and acquisitions, collaborations, joint ventures, and partnerships. Top companies profiled in the report include: Terumo BCT Inc., B. Braun Melsungen AG, Fresenius Medical Care, Asahi Kasei Medical Co. Ltd., Haemonetics Corporation and HemaCare Corporation. Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1680 The report also covers SWOT analysis and Porter’s Five Forces analysis along with feasibility analysis and investment return analysis. Key statistical data has been organized in tables, charts, diagrams, figures, and other pictorial representations. The report also offers strategic recommendations to established players as well as details on entry barriers for new entrants. Further key findings from the report suggest • Rising number of target diseases and blood disorders has led to a need for plasma and platelets across the globe. This has led a rise in the demand for apheresis which consequently has led to an increase in the demand for apheresis equipment. • With the growing infrastructure there has been a rise in the number of established blood banks with proper equipment and facilities. The expansion of these blood banks has resulted in a rise in the demand for apheresis equipment. • The governments of several countries are trying to build better infrastructure for the healthcare sector. This has led to a significant increase in the demand for the equipment. • The continuous research and development for the launch of improved and more efficient equipment has, also, encouraged market demand.
WWW.REPORTSANDDATA.COM
Apheresis Equipment Market Share & Analysis, 2020-2027
Apheresis Equipment market was valued at USD 1.79 Billion in 2019 and is expected to reach USD 3.02 Billion by the year 2027, at a CAGR of 7.7%. The major players in this industry are Terumo BCT Inc., Frost & Sullivan, B. Braun Melsungen AG, Fresenius Kabi, Fresenius Medical Care, etc.
0 Comments 0 Shares